Berkeley Lights, Inc. announced that Eric D. Hobbs, Ph.D. will transition from his role as chief executive officer (CEO) to president of the Antibody Therapeutics business line. The Company is initiating a search for a new CEO. Dr. Hobbs will continue to serve in his role as CEO until the appointment of his successor.
Bruker Cellular Analysis, Inc.
Equities
BLI
US0843101017
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+17.36% | 44.44B | |
+42.49% | 40.03B | |
-10.80% | 37.68B | |
+30.35% | 31.46B | |
-9.23% | 27.29B | |
+12.69% | 26.29B | |
+42.63% | 13.8B | |
+29.68% | 12.46B | |
-7.56% | 11.26B |